Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$479,715,664
+$249,488,037 QoQ
Shares Held
399,953
+59.8% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
#151
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 72%
Shared 28%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$2,998,575
CallShares
2,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tidal Investments LLC holds $1,286,079,316 across 16 Drug Manufacturers - General names. LLY ranks #1 (37.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
399,953 | $479,715,664 | |
| 2 | JNJ |
Johnson & Johnson
|
793,471 | $201,517,828 | |
| 3 | ABBV |
AbbVie Inc.
|
585,879 | $147,430,590 | |
| 4 | MRK |
Merck & Co., Inc.
|
932,100 | $119,774,849 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
545,861 | $68,964,077 | |
| 6 | AMGN |
Amgen Inc
|
178,875 | $64,774,213 | |
| 7 | PFE |
Pfizer Inc
|
1,971,885 | $47,482,989 | |
| 8 | AZN |
Astrazeneca PLC
|
248,108 | $47,046,238 |
All Filings in LLY
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $479,715,664 | 399,953 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $2,998,575 | 2,500 | Call | Defined | 2026-08-13 | |
| 2026-03-31 | $230,227,627 | 250,310 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $139,138,830 | 129,470 | Shares | Sole | 2026-02-13 | |
| 2025-12-31 | $1,397,084 | 1,300 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $47,285,924 | 44,000 | Put | Sole | 2026-02-13 | |
| 2025-09-30 | $83,785,793 | 109,811 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $68,758,442 | 88,205 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $67,533,008 | 81,768 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $69,737,848 | 90,334 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $3,140 | 6 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $43,908,958 | 49,562 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $37,245,521 | 41,138 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $29,966,240 | 38,519 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $18,047,203 | 30,960 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $14,112,016 | 26,273 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $10,549,705 | 22,495 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,420,619 | 21,608 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,013,518 | 19,171 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,716,181 | 17,678 | Shares | Sole | 2022-11-23 | |
| 2022-06-30 | $5,435,067 | 16,763 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,210,223 | 25,178 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $6,898,594 | 24,975 | Shares | Sole | 2022-02-16 | |
| 2021-09-30 | $3,110,395 | 13,462 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,605,281 | 11,351 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,427,117 | 7,639 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,021,313 | 6,049 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $737,435 | 4,982 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $734,541 | 4,474 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $659,613 | 4,755 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||